Clinical importance of precursor lesions in the pancreas.
about
Recent progress in pancreatic cancerPrevalence of unsuspected pancreatic cysts on MDCTPancreatic adenocarcinoma pathology: changing "landscape"Endoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancerPIK3CA mutations in mucinous cystic neoplasms of the pancreas.Imaging patterns of intraductal papillary mucinous neoplasms of the pancreas: an illustrated discussion of the International Consensus Guidelines for the Management of IPMN.Prevalence of incidental pancreatic cysts on 3 tesla magnetic resonance.HIPK2 deficiency causes chromosomal instability by cytokinesis failure and increases tumorigenicityHuman pancreatic cancer fusion 2 (HPC2) 1-B3: a novel monoclonal antibody to screen for pancreatic ductal dysplasia.Intraductal Papillary Mucinous Neoplasms and the Risk of Diabetes Mellitus in Patients Undergoing Resection Versus Observation.Epigenetics and epigenetic alterations in pancreatic cancer.Pancreatic cancer screening: state of the art.Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients.Loss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas.Clinical importance of Familial Pancreatic Cancer Registry in Japan: a report from kick-off meeting at International Symposium on Pancreas Cancer 2012.Diagnostic Accuracy of 256-Detector Row Computed Tomography in Detection and Characterization of Incidental Pancreatic Cystic LesionsInsights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy.Malignant Progression in IPMN: A Cohort Analysis of Patients Initially Selected for Resection or Observation
P2860
Q24626346-71A36064-0733-460C-A13A-A08909893132Q24650018-790F160A-C84D-4947-8E00-9AFC162E57F3Q26799446-49FCC4D6-818B-4171-9015-4799C5E4ACDFQ27010209-98C5087F-1133-48ED-9251-CA3C80C2FD29Q33942405-6EB3974C-460D-490A-B380-532BCB5F1AD4Q34438494-4B09C076-CD58-4560-BD8F-4B3E3DD8260EQ35208634-E9B42811-AAA7-4C62-8C2D-F223E7E8ED15Q35832992-F169B36F-C8B7-4969-9F5B-A63A174020A6Q36472807-03C565A8-80B4-406B-94F6-294FF91FECABQ36734256-61C164F5-AA22-42D1-A492-DDB406240F6AQ37041763-3224C5ED-F753-477A-8BC5-93AF2DECE56EQ37390658-422B7838-E279-4BAA-860A-AB477B8912DFQ37480736-B095A890-A64E-4940-8ECE-81B724716A75Q37558614-9ED1E906-5FC3-490C-9984-73FEFCE10464Q38100643-DB4C21E0-8968-4A51-B3A1-350CB961EC6FQ42430961-D73535FB-EC01-4866-AB35-372A2B68FED9Q47094133-6B7BCADC-6F78-468B-8BFD-F4ADEB2DCDDAQ57845750-8D0D8D83-A9F2-495C-A993-D14693BB5590
P2860
Clinical importance of precursor lesions in the pancreas.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Clinical importance of precursor lesions in the pancreas.
@en
type
label
Clinical importance of precursor lesions in the pancreas.
@en
prefLabel
Clinical importance of precursor lesions in the pancreas.
@en
P2093
P2860
P1476
Clinical importance of precursor lesions in the pancreas.
@en
P2093
Elliot K Fishman
Kieran Brune
Kurtis Campbell
Kyoichi Takaori
Marcia Canto
Scott E Kern
P2860
P304
P356
10.1007/S00534-006-1170-9
P577
2007-05-29T00:00:00Z